Status | Study |
Active, not recruiting |
Study Name: Low Rectal Cancer Study (MERCURY II) Condition: Adenocarcinoma Adenocarcinoma, Mucinous Date: 2013-11-21 |
Active, not recruiting |
Study Name: Molecular, Pathologic and MRI Investigation of the Prognostic and Redictive Importance of Extramural Venous Invasion in Rectal Cancer (MARVEL) Trial Condition: Adenocarcinoma Rectal Diseases Colorectal Neoplasms Date: 2013-11-21 |
Active, not recruiting |
Study Name: Telomere Length in Predicting Toxicity in Older Patients With Stage III-IV Colorectal Cancer Undergoing Chemotherapy Condition: Mucinous Adenocarcinoma of the Colon Muci Date: 2013-08-29 Interventions: Other: cytology specimen collection procedure |
Active, not recruiting |
Study Name: Irinotecan and Alisertib in Treating Patients With Advanced Solid Tumors or Colorectal Cancer Condition: Mucinous Adenocarcinoma of the Colon Muci Date: 2013-08-13 Interventions: Drug: irinotecan hydrochloride |
Recruiting |
Study Name: Bevacizumab, Fluorouracil, Leucovorin Calcium, and Oxaliplatin Before Surgery in Treating Patients With Stage II-III Rectal Cancer Condition: Mucinous Adenocarcinoma of the Rectum Signet Ring Adenocarcinom Date: 2013-06-04 Interventions: Biological: bevacizumab Given |
Active, not recruiting |
Study Name: Akt Inhibitor MK2206 in Treating Patients With Previously Treated Colon or Rectal Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery Condition: Colon Mucinous Adenocarcinoma Colon Signet Ring Cell Adenocarci Date: 2013-02-27 Interventions: Drug: Akt Inhibitor MK2206 Giv |
Recruiting |
Study Name: Panitumumab and Chemotherapy in Patients With Advanced Colorectal Cancer After Prior Therapy With Bevacizumab Condition: Mucinous Adenocarcinoma of the Colon Muci Date: 2013-02-25 Interventions: Biological: panitumumab Given |
Completed |
Study Name: Adherence to Survivorship Care Guidelines in Health Care Providers for Non-Small Cell Lung Cancer and Colorectal Cancer Survivor Care Condition: Adenocarcinoma of the Lung Mucinous Adenocarcinoma of the Colon Date: 2012-11-09 Interventions: Other: educational intervention |
Active, not recruiting |
Study Name: Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer Condition: Mucinous Adenocarcinoma of the Colon Muci Date: 2012-07-25 Interventions: Biological: aflibercept 4 mg/k |
Recruiting |
Study Name: Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies Condition: Acinar Cell Adenocarcinoma of the Pancreas Adenocarcinoma of the Gallbladder Date: 2012-07-16 Interventions: Drug: oxaliplatin Given IV |